A meta-analysis by Li et al. confirmed that BRAF mutation is associated with lymph node metastases, tumor stage, extrathyroidal extension, tumor size, male sex, multifocality, absence of capsule, classic PTC, and tall-cell variant PTC in PTC [6]. The gene discussed is BRAF; the disease is neoplasm.